![COMPASS trial addresses the unmet need of patients with early-relapsing TNBC](https://oncodaily.com/pub/uploads/2024/06/gustaveroussy-fronton_1-e1719325393571.jpg)
Jun 27, 2024, 16:06
COMPASS trial addresses the unmet need of patients with early-relapsing TNBC
Elie Rassy,
Gustave Roussy, shared on X:“Just out… COMPASS trial, an academic study led by Gustave Roussy, Barbara Pistilli, Thomas Grinda addresses the unmet need of patients with early-relapsing TNBC by employing innovative treatment strategies.“.
Read further.
Source: Elie Rassy/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023